Corpus Intelligence IC Memo — SSH - SPECTRUM HEALTH 2026-04-26 09:55 UTC
IC Memo — SSH - SPECTRUM HEALTH
Investment Committee Memorandum | MI | 36 beds | Grade D | EBITDA uplift $1.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH - SPECTRUM HEALTH

CCN 232029 | KENT, MI | 36 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SSH - SPECTRUM HEALTH is a 36-bed suburban community hospital in KENT, MI with $21.6M in net patient revenue and a 0.6% operating margin. The hospital serves a payer mix of 23.4% Medicare, 3.8% Medicaid, and 72.8% commercial.

Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.6% to 8.0% (+736bps).

Net Revenue HCRIS$21.6M
Current EBITDA COMPUTED$134K
Operating Margin COMPUTED0.6%
Occupancy HCRIS80.8%
Revenue / Bed COMPUTED$601K
Net-to-Gross HCRIS19.4%
Distress Probability ML40.3%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
74
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of 0.6% places it above the state median. Among 74 size-comparable peers (18-72 beds), the median margin is -3.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-72), prioritizing same-state peers. 74 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH - SPECTRUM HEALTH (Target)MI36$21.6M0.6%
TRINITY HEALTH LIVINGSTONMI42$200.4M15.2%
MYMICHIGAN MEDICAL CENTER ALMAMI49$142.2M-5.9%
SPECTRUM HEALTH UNITED MEMORIAMI45$129.4M9.7%
DICKINSON COUNTY HEALTHCARE SYMI49$126.3M-4.7%
PROMEDICA HICKMAN HOSPITALMI58$124.7M5.5%
MUNSON HEALTHCARE CADILLAC HOSMI49$122.7M1.0%
MCLAREN CENTRAL MICHIGANMI49$118.9M-35.3%
SPECTRUM HEALTH GERBERMI25$116.2M16.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$454K+210bp18mo
Cost to Collect4.5%2.5%$432K+200bp12mo
Denial Rate Reduction12.0%6.5%$428K+198bp12mo
A/R Days Reduction5200.0%3800.0%$263K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$454K
Cost to Collect
$432K
Denial Rate Reduction
$428K
A/R Days Reduction
$263K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.6M
Current EBITDA$134K
+ RCM Uplift+$1.6M
Pro Forma EBITDA$1.7M
Current Margin0.6%
Pro Forma Margin8.0%
WC Released (1x)$829K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$206K$16.8M81.37x141.0%
Base (11x exit)10.0x11.0x$206K$18.5M89.83x145.9%
Bull Case9.0x11.0x$186K$23.9M128.44x164.1%
Bull (12x exit)9.0x12.0x$186K$26.1M140.41x168.8%
Bear Case11.0x10.0x$227K$8.8M38.64x107.7%
Bear (11x exit)11.0x11.0x$227K$9.7M42.83x112.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 74 hospitals with 18-72 beds
  • Same-state prioritization (n=75)
  • Comp margins: P25=-12.3% / P50=-3.3% / P75=8.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.